Nephron Pharma Recalls 2+ Million Products

The South Carolina based company recently invested $215.8 million in the facility that produces generic inhalation and suspension products.

Screen Shot 2022 04 18 At 2 42 14 Pm
Getty Images

A recent WIS News article discussed a massive recall from Nephron Sterile Compounding Center. Somewhat ironically, 2.1 million doses of medicine and medical equipment were recalled due to “lack of assurance of sterility.” The recall began on May 18th, and includes a total of 2,158,351 pieces of medicine and equipment including syringes and bags.

Fresh from the show floor: pharma packaging innovations for 2026
Serialization mandates. Containment demands. Sterile barrier requirements. Our editors found the pharma packaging innovations addressing your biggest challenges at PACK EXPO Las Vegas. Get your free curated report now.
GET YOUR COPY
Fresh from the show floor: pharma packaging innovations for 2026